Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT03037580 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT03037580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03037580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Lead sponsor
United Therapeutics
Phase
Phase 3
Overall status
Terminated
Start date
August 15, 2017
Completion date
December 3, 2019
Enrollment
84 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, pulmonary hypertension